Niraparib Monotherapy as Maintain and Recurrent Treatment of Endometrial Serous Carcinoma

NCT04716686 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

83

Enrollment

OTHER

Sponsor class

Conditions

Endometrial Carcinoma
Serous Carcinoma

Interventions

DRUG: Niraparib

Sponsor

Shandong University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]